跳至主要内容
临床试验/ACTRN12617001233314
ACTRN12617001233314招募中未知

An investigation into the clinical effectiveness and cost benefit of an intensive therapeutic lifestyle intervention for people with Type 2 Diabetes.

Avondale College of Higher Education0 个研究点目标入组 150 人开始时间: 2017年8月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • A current diagnosis of Type 2 Diabetes Mellitus
  • Over the age of 18 years

排除标准

  • Persons will be ineligible for the study if:
  • a.they are aged less than 18 years
  • b.the consulting medical practitioner considers that an alteration in nutrient or calorie consumption or that the participating in regular moderate exercise could result in an increased health risk. This may include but may not be limited to:
  • i. persons having a history of uncontrolled hypertension with consistent resting blood pressure readings greater than 180mmHg systolic and or greater than 110 mm Hg diastolic;
  • ii.persons having a BMI lower than 21 kg/m²; and making use of weight-loss medication;
  • iii.persons experiencing recurrent chest pain or unstable angina;
  • iv.pregnant or lactating females, or females planning to become pregnant in the next year;
  • v.persons having undergone angioplasty or having had a myocardial infarction or cardiac surgery within the previous 3 months;
  • c. they have any condition that precludes the potential participant from increasing their level of physical activity;
  • d..they have any physical condition or language barrier that would preclude them from understanding or safely adopting the lifestyle changes recommended by the CHIP intervention.

研究者

发起方
Avondale College of Higher Education

相似试验